Changgeng Ruan

4.4k total citations
202 papers, 3.1k citations indexed

About

Changgeng Ruan is a scholar working on Hematology, Immunology and Molecular Biology. According to data from OpenAlex, Changgeng Ruan has authored 202 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 133 papers in Hematology, 54 papers in Immunology and 49 papers in Molecular Biology. Recurrent topics in Changgeng Ruan's work include Platelet Disorders and Treatments (77 papers), Complement system in diseases (33 papers) and Blood Coagulation and Thrombosis Mechanisms (25 papers). Changgeng Ruan is often cited by papers focused on Platelet Disorders and Treatments (77 papers), Complement system in diseases (33 papers) and Blood Coagulation and Thrombosis Mechanisms (25 papers). Changgeng Ruan collaborates with scholars based in China, United States and Japan. Changgeng Ruan's co-authors include Xia Bai, Ziqiang Yu, Zhaoyue Wang, Lijuan Cao, Ningzheng Dong, Miao Jiang, Yun Ling, Xiang-shan Cao, Kesheng Dai and Xiaoping Du and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Changgeng Ruan

187 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Changgeng Ruan China 32 1.6k 856 663 375 374 202 3.1k
Emma C. Josefsson Australia 29 1.6k 1.0× 1.2k 1.4× 647 1.0× 312 0.8× 251 0.7× 61 3.0k
Marijke J. E. Kuijpers Netherlands 33 1.7k 1.1× 700 0.8× 511 0.8× 388 1.0× 350 0.9× 81 3.2k
Hartmut Weiler United States 35 2.2k 1.4× 1.2k 1.3× 691 1.0× 275 0.7× 400 1.1× 121 4.5k
Glenn Merrill‐Skoloff United States 15 1.5k 1.0× 605 0.7× 564 0.9× 192 0.5× 248 0.7× 25 2.8k
Jesse W. Rowley United States 26 1.1k 0.7× 1.1k 1.2× 904 1.4× 548 1.5× 236 0.6× 55 3.3k
Hirokazu Kashiwagi Japan 29 1.7k 1.1× 831 1.0× 619 0.9× 307 0.8× 510 1.4× 117 3.4k
Elisabeth M. Battinelli United States 22 929 0.6× 1.1k 1.3× 357 0.5× 683 1.8× 211 0.6× 54 2.8k
Judith M.E.M. Cosemans Netherlands 38 2.2k 1.4× 674 0.8× 477 0.7× 176 0.5× 432 1.2× 73 3.6k
Hetty C. de Boer Netherlands 33 620 0.4× 1.7k 2.0× 663 1.0× 436 1.2× 518 1.4× 73 3.7k
Paul Friese United States 22 1.4k 0.9× 487 0.6× 770 1.2× 345 0.9× 177 0.5× 35 2.6k

Countries citing papers authored by Changgeng Ruan

Since Specialization
Citations

This map shows the geographic impact of Changgeng Ruan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changgeng Ruan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changgeng Ruan more than expected).

Fields of papers citing papers by Changgeng Ruan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changgeng Ruan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changgeng Ruan. The network helps show where Changgeng Ruan may publish in the future.

Co-authorship network of co-authors of Changgeng Ruan

This figure shows the co-authorship network connecting the top 25 collaborators of Changgeng Ruan. A scholar is included among the top collaborators of Changgeng Ruan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changgeng Ruan. Changgeng Ruan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xia, Yue, Jun Liu, Biao Yang, et al.. (2024). Essential role of glycoprotein Ibα in platelet activation. Blood Advances. 8(13). 3388–3401. 3 indexed citations
2.
Huang, Lulu, Yuji Kondo, Lijuan Cao, et al.. (2024). Novel GNE missense variants impair de novo sialylation and cause defective angiogenesis in the developing brain in mice. Blood Advances. 8(4). 991–1001. 2 indexed citations
3.
Pang, Ningbo, Yingwei Li, Chunliang Liu, et al.. (2023). Cyclic thrombocytopenia associated with estradiol: a case report. Hematology. 28(1). 2240140–2240140.
4.
Jiang, Jiang, Lijuan Cao, Miao Jiang, et al.. (2021). Nonsense‐mediated mRNA decay efficiency influences bleeding severity in ITGA2B c. 2659C  > T (p. Q887X ) knock‐in mice. Clinical Genetics. 100(2). 213–218. 2 indexed citations
5.
Jiang, Yizhi, Yuji Kondo, Miao Jiang, et al.. (2020). Novel mutations in ADAMTS13 CUB domains cause abnormal pre‐mRNA splicing and defective secretion of ADAMTS13. Journal of Cellular and Molecular Medicine. 24(7). 4356–4361. 4 indexed citations
6.
Shao, Bojing, Christopher Hoover, Jianhua Song, et al.. (2020). Monocyte upregulation of podoplanin during early sepsis induces complement inhibitor release to protect liver function. JCI Insight. 5(13). 22 indexed citations
7.
Tang, Yaqiong, Miao Miao, Shiyu Han, et al.. (2018). Prognostic value and clinical feature of SF3B1 mutations in myelodysplastic syndromes: A meta-analysis. Critical Reviews in Oncology/Hematology. 133. 74–83. 11 indexed citations
8.
Zhang, Wenjuan, Jiaqian Qi, Wenhong Shen, et al.. (2017). Clinical significance of circulating microparticles in Ph− myeloproliferative neoplasms. Oncology Letters. 14(2). 2531–2536. 37 indexed citations
9.
Ling, Jing, Fei Shen, Liqian Xie, et al.. (2016). [Identification of Monoclonal Antibodies against von Willebrand Factor Cleaving Protease (ADAMTS13) and Their Function].. PubMed. 24(4). 1104–9. 1 indexed citations
10.
Fu, Jianxin, et al.. (2016). [Stable expression of recombinant human podoplanin in Chinese hamster ovary (CHO) cells].. PubMed. 32(1). 25–8. 3 indexed citations
11.
Xiang, Binggang, Guoying Zhang, Shaojing Ye, et al.. (2015). Characterization of a Novel Integrin Binding Protein, VPS33B, Which Is Important for Platelet Activation and In Vivo Thrombosis and Hemostasis. Circulation. 132(24). 2334–2344. 30 indexed citations
12.
Zeng, Qingshu, Lingyan Zhu, Lili Tao, et al.. (2011). Relative efficacy of steroid therapy in immune thrombocytopenia mediated by anti‐platelet GPIIbIIIa versus GPIbα antibodies. American Journal of Hematology. 87(2). 206–208. 74 indexed citations
13.
Liu, Yanhui, Zhaoyue Wang, Miao Jiang, et al.. (2010). The expression of annexin II and its role in the fibrinolytic activity in acute promyelocytic leukemia. Leukemia Research. 35(7). 879–884. 57 indexed citations
14.
Ruan, Changgeng. (2010). Sepsis-induced disseminated intravascular coagulation with features of thrombotic thrombocytopenic purpura:a fatal fulminant syndrome. 1 indexed citations
15.
Liang, Jianying, et al.. (2010). The 2008 revision of the World Health Organization (WHO) classification of MDS.. 30(5). 416–421. 10 indexed citations
16.
Zhao, Xiaojuan, Zhaoyue Wang, Minghua Jiang, et al.. (2010). [Inherited dysfibrinogenemia caused by Arg16His mutation in alpha chain of fibrinogen.].. PubMed. 31(3). 154–6.
17.
Ruan, Changgeng. (2008). Preparation and Characterization of Monoclonal Antibodies Against Human von Willebrand Factor A1 Domain. 2 indexed citations
18.
Ling, Yun, Xiang-shan Cao, Ziqiang Yu, et al.. (2007). [Alterations of CD4+ CD25+ regulatory T cells in patients with idiopathic thrombocytopenic purpura].. PubMed. 28(3). 184–8. 10 indexed citations
19.
An, Guangyu, Ningzheng Dong, Bojing Shao, Mingqing Zhu, & Changgeng Ruan. (2002). [Preparation and characterization of a single chain antibody fragment of mAb SZ-21 against platelets GPIIIa].. PubMed. 23(9). 480–2. 4 indexed citations
20.
Bai, Xia, Xiaodong Xi, Jie Xu, & Changgeng Ruan. (1999). Preparation and identification of monoclonal antibodies against human urokinase receptor. 19(12). 1268–1270. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026